Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon May 28, 2022 9:26am
75 Views
Post# 34714233

RE:RE:RE:Avenanthramide clinical trial: End of Q2 or early Q3

RE:RE:RE:Avenanthramide clinical trial: End of Q2 or early Q3 Subjects shouldn't be taking milk with the AV pill in the MHI study coming up.

https://www.researchgate.net/publication/6319908_Avenanthramides_Are_Bioavailable_and_Have_Antioxidant_Activity_in_Humans_after_Acute_Consumption_of_an_Enriched_Mixture_from_Oats


prophetoffact wrote:




Tranilast is the synthetic avenanthramide and has been of interest for many diseases. CZO could have a potent neutraceutical option for lifestyle diseases like cardiovascular disease. CZO's avenanthramide could be the Aveeno of Tranilast, in a sense. That could be important for many taking a pill every day. Safety is likely in the bag given results with Tranilast, "several trials have shown that it has very low adverse effects and it is generally well tolerated by patients.          

 


<< Previous
Bullboard Posts
Next >>